In Vitro Evaluation of the Antiviral Activity of Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) Against Mayaro Virus
Viruses · 14.02.2025 · 17 (2) · 258
DOI: 10.3390/v17020258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 14.02.2025. Verfasst von Pâmela Jóyce Previdelli da Conceição und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil. Hauptthemen laut MEDLINE: Catechin, Antiviral Agents, Alphavirus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Secretaría Nacional de Ciencia, Tecnología e Innovación de Panamá (SENACYT), Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
The Mayaro virus (MAYV), Togaviridae family, genus Alphavirus, has caused several sporadic outbreaks, affecting countries in the Americas. Currently, there are no licensed drugs against MAYV, requiring the search for effective antiviral compounds. Thus, this study aimed to evaluate the antiviral potential of polyphenol (-)-epigallocatechin-3-gallate (EGCG) against MAYV infection, in vitro. Antiviral assays against MAYV were performed in BHK-21 and Vero E6 cells. In addition, molecular docking was performed with EGCG and the MAYV non-structural and structural proteins. EGCG showed a significant protective effect against MAYV infection in both cell lines. The virucidal assay showed an effect on extracellular viral particles at the entry stage into BHK-21 cells. Finally, it also showed significant inhibition in the post-entry stages of the MAYV replication cycle, acting on the replication of the genetic material and late stages, such as assembly and release. In addition, the MAYV proteins E1 and nsP1 were significantly inhibited by the EGCG treatment in BHK-21 cells. Molecular docking analysis also showed that EGCG could interact with MAYV Capsid and Envelope proteins (E1 and E2). Therefore, this study shows the potential of EGCG as a promising antiviral against MAYV, as it acts on different stages of the MAYV replication cycle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.
- Institut de Recherche en Infectiologie de Montpellier, Centre National de la Recherche Scientifique (CNRS), 34000 Montpellier, France.
- Laboratory of Antiviral Research, Institute of Biomedical Science, ICBIM/UFU, Uberlândia 38405-302, MG, Brazil.
- Physics Department, São Paulo State University-UNESP, São José do Rio Preto 15385-000, SP, Brazil.
- Grupo de Biología Celular y Molecular de Arbovirus, Departamento de Genómica y Proteómica, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá City 0816-02593, Panama.
- Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.
ORCID-Profile: Pâmela Jóyce Previdelli da Conceição, Gabriela Miranda Ayusso, Fábio Rogério Moraes, Paola Elaine Galán-Jurado, José González-Santamaría, Cíntia Bittar, Bo Zhang, Ana Carolina Gomes Jardim, Paula Rahal, Marilia Freitas Calmon
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Secretaría Nacional de Ciencia, Tecnología e Innovación de Panamá (SENACYT)
- Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)
- Ministerio de Economía y Finanzas de Panamá (MEF)
- São Paulo Research Foundation
- Sistema Nacional de Investigación (SNI) from Secretaría Nacional de Ciencia, Tecnología e Innovación de Panamá (SENACYT)
- National Council for Scientific and Technological Development—CNPq
Zitieren
APA
da Conceição, P. J. P., Ayusso, G. M., Carvalho, T., Duarte Lima, M. L., Marinho, M. D. S., Moraes, F. R., Galán-Jurado, P. E., González-Santamaría, J., Bittar, C., Zhang, B., Jardim, A. C. G., Rahal, P., & Calmon, M. F. (2025). In Vitro Evaluation of the Antiviral Activity of Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) Against Mayaro Virus. Viruses, 17(2), 258. https://doi.org/10.3390/v17020258
Vancouver
da Conceição PJP, Ayusso GM, Carvalho T, Duarte Lima ML, Marinho MDS, Moraes FR, et al. In Vitro Evaluation of the Antiviral Activity of Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) Against Mayaro Virus. Viruses. 2025;17(2):258. doi:10.3390/v17020258
BibTeX
@article{daConceio2025,
author = {da Conceição, Pâmela Jóyce Previdelli and Ayusso, Gabriela Miranda and Carvalho, Tamara and Duarte Lima, Maria Leticia and Marinho, Mikaela Dos Santos and Moraes, Fábio Rogério and Galán-Jurado, Paola Elaine and González-Santamaría, José and Bittar, Cíntia and Zhang, Bo and Jardim, Ana Carolina Gomes and Rahal, Paula and Calmon, Marilia Freitas},
title = {In Vitro Evaluation of the Antiviral Activity of Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) Against Mayaro Virus},
journal = {Viruses},
year = {2025},
volume = {17},
number = {2},
pages = {258},
doi = {10.3390/v17020258}
}
EUVIMED